(Q52868368)
Statements
Neoral vs Sandimmun: interim results of a randomized trial of efficacy and safety in preventing acute rejection in new renal transplant recipients. The U. K. Neoral Study Group. (English)
J P Lodge
S G Pollard
1 February 1997
29
1-2
272-273